Measurements of Serum S-100B Protein: Effects of Storage Time and Temperature on Pre-Analytical Stability
- 15 January 2003
- journal article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 41 (5), 700-703
- https://doi.org/10.1515/cclm.2003.106
Abstract
Measurement of S-100B protein in serum or cerebrospinal fluid is increasingly used as a molecular marker of brain damage. However, there is no information about the pre-analytical in vitro stability of S-100B. We have investigated whether storing blood samples at different time periods and conditions affected the measured levels of S-100B protein. Blood samples were taken from 29 neurosurgical patients with normal serum S-100B values and from seven patients with increased serum S-100B values. Blood samples were immediately divided into nine aliquots for measuring S-100B immediately and after 4, 8, 12, and 24 hours, stored at room temperature or at 4 degrees C. Measurement of S-100B was performed using the LIAISON assay (Byk-Sangtec Diagnostica, Dietzenbach, Germany). Moreover, in 10 additional patients the effect of freezing the serum and thawing the sample after 24 hours was investigated. There were no differences between the results of S-100B measurements after storing the sample at different temperatures and time periods. There was no trend towards higher or lower values in all three groups. Therefore, blood samples may be collected as part of the daily clinical routine without time constraint and even stored overnight without affecting S-100B serum levels when measured with the LIAISON Sangtec 100 assay.Keywords
This publication has 13 references indexed in Scilit:
- Astroglial Protein S-100 Is an Early and Sensitive Marker of Hypoxic Brain Damage and Outcome After Cardiac Arrest in HumansCirculation, 2001
- S100B as a predictor of size and outcome of stroke after cardiac surgeryThe Annals of Thoracic Surgery, 2001
- Traumatic Brain Damage: Serum S-100 Protein Measurements Related to Neuroradiological FindingsJournal of Neurotrauma, 2000
- Temporal Profile of Release of Neurobiochemical Markers of Brain Damage After Traumatic Brain Injury Is Associated With Intracranial Pathology as Demonstrated in Cranial Computerized TomographyJournal of Neurotrauma, 2000
- The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre studyBrain Injury, 2000
- Serum S-100B Protein in Severe Head InjuryNeurosurgery, 1999
- Early Neurobehavioral Outcome After Stroke Is Related to Release of Neurobiochemical Markers of Brain DamageStroke, 1999
- Serum markers of brain damage and outcome prediction in patients after severe head injuryBritish Journal of Neurosurgery, 1999
- S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA InfarctionStroke, 1997
- Serum S-100 Protein, Relationship to Clinical Outcome in Acute StrokeAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1997